Food and non-alcoholic drink prices are out of control

Vegetables are on sale Sunday at a traditional market in central Seoul. According to data provided by the Organization for Economic Co-operation and Development (OECD) on Saturday, the price of food and non-alcoholic beverages rose 5% year-on-year in the third quarter in Korea, placing the country fifth out of 38 …

Read More »

2 major market risks for 2022, according to Bank of America

Markets should be wary of high inflation and the potential spread of new COVID variants in 2022, a new report from the Bank of America (BAC) warns. “Future waves of COVID are the biggest downside risk,” the report notes. “On the upside, supply is waking up to meet the gains …

Read More »

South Korea defers crypto tax, looking for votes? – Bitcoinist.com

The Strategy and Finance Committee of the South Korean National Assembly has approved an amendment to defer to 2023 the imposition that imposes a 20% annual capital gains tax for crypto trading with more than 2 .5 million won (US $ 2,125) in revenue, just after the same tax was …

Read More »

Vietnam, Taiwan cross US Treasury currency thresholds, but no manipulator labels

The United States Department of the Treasury is seen in Washington, DC, the United States, on August 30, 2020. REUTERS / Andrew Kelly / File Photo Register now for FREE and unlimited access to reuters.com Register now December 3 (Reuters) – Vietnam and Taiwan again crossed US Treasury thresholds for …

Read More »

Ascletis announces the inclusion in the new catalog of the Chinese national list of reimbursed drugs (NRDL) of the ASCLEVIR® / GANOVO® regimen, an all-oral direct anti-HCV therapy

HANGZHOU, China and SHAOXING, China, December 3, 2021 / PRNewswire / – Ascletis Pharma Inc. (HKEX: 1672) today announced that its all-oral direct anti-hepatitis C virus (HCV) ASCLEVIR® (Ravidasvir) / GANOVO® (Danoprevir) has been included in the Catalog of medicines for basic national health insurance, occupational accident insurance and maternity …

Read More »

Asian stocks climb but Omicron worries leave markets nervous

By Alun John HONG KONG (Reuters) – Asian stocks edged up in choppy trading on Thursday, helped by advances in Chinese real estate stocks, although fears over the Omicron variant of the novel coronavirus have capped gains regionally. Remarks by Fed Chairman Jerome Powell also weighed on stock markets, reiterating …

Read More »

COVID-19: Asian factories report stability

APPARENT THREAT: There are growing concerns that the Omicron variant may affect industrial production, which has just recovered from plant closures of the Delta variant. Manufacturing activity in Asia outside of China stabilized last month amid easing lockdown and border restrictions, putting the industry on track to face a possible …

Read More »

SQZ Biotechnologies Announces Acceptance by Roche Accelerator in China | Business and finance

WATERTOWN, Mass .– (BUSINESS WIRE) – December 1, 2021– SQZ Biotechnologies Company (NYSE: SQZ), a cell therapy company developing new treatments for multiple therapeutic areas, today announced that its Chinese initiative has been accepted by the Roche Accelerator. Launched earlier this year, the accelerator is Roche’s first internal accelerator in …

Read More »

Latest updates: German Scholz favors compulsory vaccines amid increasing Covid cases

Olaf Scholz, the Chancellor-designate of Germany, said he was in favor of compulsory vaccination for all, increasing the likelihood that the country will follow Austria in creating a legal obligation for all of its population to obtain the vaccine . The decision to go ahead with the mandate could come …

Read More »

Enlitic Becomes First U.S. AI Imaging Company To Receive Regulatory Approval To Market In Japan

SAN FRANCISCO, November 30, 2021 / PRNewswire / – Enlitic, in collaboration with Konica Minolta Inc. and Marubeni Corporation, today announced that its AI-based product for chest x-ray analysis – CXR-AI – has received approval from Japanese regulators and will be available in the trade through Japan. With this approval, …

Read More »